Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 19 min 33 sec ago

Spine Wave Announces the Commercial Launch of the Titanium Coated StaXx(R) XD Expandable Device: StaXx(R) XDTi

Tue, 10/13/2015 - 13:39
StaXx(R) XDTi: The Modulus of Stacked PEEK, The Surface of Titanium, All in an Expandable Implant SHELTON, CT--(Healthcare Sales & Marketing Network) - Spine Wave, Inc. is committed to the commercialization of high-quality, innovative medical devices f...
Devices, Orthopaedic, Neurosurgery, Product Launch
Spine Wave, StaXx, Leva Interbody, StaXx XDTi, spine surgery

GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence

Tue, 10/13/2015 - 13:32
Trial to evaluate an orally administered SARM in postmenopausal women with stress urinary incontinence Preclinical data demonstrates a SARM can increase pelvic floor muscle mass and potentially improve outcomes in women with SUI MEMPHIS, Tenn.--(Heal...
Biopharmaceuticals, Urology, FDA
GTx, stress urinary incontinence, enobosarm

Timothy P. Walbert Joins Sucampo's Board of Directors

Tue, 10/13/2015 - 13:27
BETHESDA, Md., Oct. 13, 2015 -- (Healthcare Sales & Marketing Network) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (SCMP), a global biopharmaceutical company, today announced that Timothy P. Walbert has joined Sucampo's Board of Directors. Mr. Walbert curre...
Biopharmaceuticals, Personnel
Sucampo Pharmaceuticals

Installation Completed for Elekta MRI-guided linear Accelerator at MD Anderson Cancer Center

Tue, 10/13/2015 - 13:21
System is first of its kind in the United States HOUSTON, October 13, 2015 -- (Healthcare Sales & Marketing Network) -- The University of Texas MD Anderson Cancer Center, Elekta and Philips teams recently completed installation of the first high field ...
Devices, Oncology
Elekta, MRI-guided linear accelerator, MR linac, radiotherapy

Abbott Announces Positive Clinical Results of Absorb(TM), the Naturally Dissolving Heart Stent

Mon, 10/12/2015 - 21:23
ABSORB III Pivotal Trial, Designed to Support Regulatory Approval in the U.S., Meets Primary Endpoint; ABSORB China Pivotal Trial Meets Primary Endpoint Latest Data Show that Absorb Performs as well as the Market-leading, Metallic Drug Eluting Stent ...
Devices, Interventional, Cardiology
Abbott, ABSORB III trial, Absorb stent, coronary stent, everolimus

CorVascular and Vasamed Enter into Collaboration and Distribution Agreement for Peripheral Vascular Diagnostic Systems

Mon, 10/12/2015 - 18:50
MINNEAPOLIS, Oct. 12, 2015 -- (Healthcare Sales & Marketing Network) -- CorVascular Diagnostics, LLC, a Minneapolis-based medical technology company that designs and distributes advanced peripheral vascular diagnostic solutions, announced today it has ent...
Devices, Distribution
CorVascular Diagnostics, Vasamed, SensiLase

Uptake Medical Announces First-in-Human Lung Cancer Tumor Ablation Using Intervapor(R) Targeted Vapor Therapy

Mon, 10/12/2015 - 18:44
Clinicians Successfully Isolate, Ablate Lung Tumor via Non-surgical Bronchoscopic Approach TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--Medical technology innovator Uptake Medical announced today that clinicians have successfully performed th...
Devices, Oncology
Uptake Medical, InterVapor, Targeted Vapor Therapy

Endologix Announces FDA Approval of AFX(R)2 Bifurcated Endograft System

Mon, 10/12/2015 - 18:13
IRVINE, Calif., Oct. 12, 2015 -- (Healthcare Sales & Marketing Network) -- Endologix, Inc. (ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval f...
Devices, Interventional, FDA
Endologix, AFX2, Bifurcated Endograft, abdominal aortic aneurysm

Teva Announces Exclusive Launch of Generic Avodart(R) Capsules in the United States

Mon, 10/12/2015 - 18:10
JERUSALEM--(Healthcare Sales & Marketing Network)--Teva Pharmaceutical Industries Ltd., (TEVA) today announced the exclusive launch of the generic equivalent to Avodart® (dutasteride) capsules, 0.5 mg, in the United States. Dutasteride is a 5 alpha-red...
Biopharmaceuticals, Urology, Generics, Product Launch
Teva Pharmaceutical, Avodart, dutasteride, benign prostatic hyperplasia

Varian Medical Systems Receives CE Mark for its Latest ProBeam(R) Proton Therapy System

Mon, 10/12/2015 - 18:06
PALO ALTO, Calif., Oct. 12, 2015 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR) has received CE Mark for its latest ProBeam® proton therapy system. The CE Mark allows Varian to begin installation of the newest version of it...
Devices, Oncology, Regulatory
Varian Medical Systems, ProBeam, proton therapy, radiotherapy

Fate Therapeutics Announces Leadership Transition

Mon, 10/12/2015 - 18:04
Scott Wolchko, a Fate Founder, to Succeed Christian Weyer as President and CEO Effective December 1, 2015 Additional Leadership Changes Enhance Fate Executive Team SAN DIEGO, Oct. 12, 2015 -- (Healthcare Sales & Marketing Network) -- Fate Therapeutic...
Biopharmaceuticals, Oncology, Personnel
Fate Therapeutics, PROHEMA, immunotherapeutic

Heron Therapeutics Appoints Neil J. Clendeninn, M.D., Ph.D. as Senior Vice President and Chief Medical Officer

Mon, 10/12/2015 - 18:00
REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Heron Therapeutics, Inc. (HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs, today announced ...
Biopharmaceuticals, Personnel
Heron Therapeutics, SUSTOL, granisetron

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

Mon, 10/12/2015 - 17:56
With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--...
Devices, Cardiology, Regulatory
St. Jude Medical, HeartMate 3, Ventricular Assist

NuVasive Receives First Ever FDA 510(k) Clearance of Cervical Corpectomy Cage

Mon, 10/12/2015 - 13:31
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today the first ever FDA 510(k) cl...
Devices, Orthopaedic, Neurosurgery, FDA
NuVasive, X-Core Mini VBR, corpectomy, spine surgery

Seven US Medical Centers to Acquire Elekta's New Leksell Gamma Knife Icon Brain Radiosurgery System

Mon, 10/12/2015 - 13:25
ATLANTA, October 12, 2015 -- (Healthcare Sales & Marketing Network) -- Patients in the United States with brain cancer or any of a range of other neurological disorders will soon have access to the most sophisticated system for the radiosurgical treatment...
Devices, Neurosurgery, Oncology
Elekta, Leksell, Gamma Knife, radiosurgery, radiotherapy

Cook Medical Expands Global Recall of Select Sizes of Beacon Tip Angiographic Catheters

Sat, 10/10/2015 - 04:00
BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--On October 7, 2015, Cook Medical initiated a voluntary recall for select sizes of Beacon® Tip Angiographic Catheters. This recall includes all lots of these select sizes of the Beacon® Tip ...
Devices, Cardiology, Radiology, Product Recall
Cook Medical, Beacon Tip, Angiographic Catheter

Sorin And Cyberonics Announce Appointment Of Remaining Post-Merger Directors Of Combined Company

Fri, 10/09/2015 - 17:47
MILAN and HOUSTON, Oct. 9, 2015 -- (Healthcare Sales & Marketing Network) -- Sorin S.p.A. (MTA; Reuters Code: SORN.MI) ("Sorin"), a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. (NAS...
Devices, Cardiology, Neurology, Personnel, Acquisitions
Cyberonics, Sorin Group, LivaNova

Aortica Corporation Strengthens Executive Team

Fri, 10/09/2015 - 15:08
Shannon Eubanks Joins Start Up Aortica™ Corp. as Vice President of Operations to Lead Development of the AortaFit™ System BELLEVUE, Wash.--(Healthcare Sales & Marketing Network)--Aortica™ Corporation, an early stage privately held company focused on the...
Devices, Interventional, Personnel
Aortica, abdominal aortic aneurysm

BioBlast Pharma Augments Leadership Team

Fri, 10/09/2015 - 15:06
Appoints Former Aptalis and Novartis Executive, Theresa M. Stevens, as Chief Corporate Development Officer NEW HAVEN, Conn., Oct. 9, 2015 -- (Healthcare Sales & Marketing Network) -- BioBlast Pharma Ltd., (ORPN), a clinical-stage biotechnology company c...
Biopharmaceuticals, Personnel
BioBlast Pharma

Biogen Announces Departure of Tony Kingsley

Fri, 10/09/2015 - 15:04
John Cox to Lead Commercial Operations on Interim Basis CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Biogen (BIIB) today announced that Tony Kingsley, executive vice president, Global Commercial Operations, will leave the company and a sear...
Biopharmaceuticals, Personnel

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong